Literature DB >> 11201771

The impact of allergies and allergy treatment on worker productivity.

W N Burton1, D J Conti, C Y Chen, A B Schultz, D W Edington.   

Abstract

Allergic disorders are a chronic and highly prevalent condition in the general population and the workforce. Their effect on workers and corporate costs go beyond the direct cost of treatment, as the condition can lower a worker's productivity. Previous research includes estimates of the decrease in productivity associated with allergic disorders. None of these studies, however, offered an objective measure of how worker productivity is affected by allergic disorders. In the present study, the productivity of telephone customer service representatives suffering from allergic disorders is examined before, during, and after the ragweed pollen season. In addition, these workers were surveyed as to the type of medication they used in response to their condition. A significant correlation was observed between an increase in pollen counts and a decrease in productivity for workers with allergies. Compared with workers without allergies, employees with allergies who reported using no medication showed a 10% decrease in productivity. No differences were observed among workers with allergies using different types of medications, although the medication groups had significantly higher productivity than the no-medication group. The expected lowered productivity of those workers with allergies who used sedating antihistamines may have been offset by their relatively lower level of symptom severity and by the nature of the job and the productivity measures used.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201771     DOI: 10.1097/00043764-200101000-00013

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  12 in total

Review 1.  Employers' benefits from workers' health insurance.

Authors:  Ellen O'Brien
Journal:  Milbank Q       Date:  2003       Impact factor: 4.911

Review 2.  The economic burden of allergic rhinitis: a critical evaluation of the literature.

Authors:  Shelby D Reed; Todd A Lee; Douglas C McCrory
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Effects of green buildings on employee health and productivity.

Authors:  Amanjeet Singh; Matt Syal; Sue C Grady; Sinem Korkmaz
Journal:  Am J Public Health       Date:  2010-07-15       Impact factor: 9.308

4.  Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.

Authors:  Eef L Theunissen; Annemiek Vermeeren; Johannes G Ramaekers
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

5.  Validation of the work and health interview.

Authors:  Walter F Stewart; Judith A Ricci; Carol Leotta; Elsbeth Chee
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Welfare reform and health insurance: consequences for parents.

Authors:  Jane L Holl; Kristen Shook Slack; Amy Bush Stevens
Journal:  Am J Public Health       Date:  2005-02       Impact factor: 9.308

Review 7.  Employee health and presenteeism: a systematic review.

Authors:  Alyssa B Schultz; Dee W Edington
Journal:  J Occup Rehabil       Date:  2007-07-25

Review 8.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.

Authors:  Wayne N Burton; Stephen H Landy; Kristen E Downs; M Chris Runken
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

9.  Natural history of upper extremity musculoskeletal symptoms and resulting work limitations over 3 years in a newly hired working population.

Authors:  Bethany T Gardner; Ann Marie Dale; Alexis Descatha; Bradley Evanoff
Journal:  J Occup Environ Med       Date:  2014-06       Impact factor: 2.162

Review 10.  The cost and impact of health conditions on presenteeism to employers: a review of the literature.

Authors:  Alyssa B Schultz; Chin-Yu Chen; Dee W Edington
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.